Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: The Business Research Company | PRODUCT CODE: 1063047

Cover Image

PUBLISHER: The Business Research Company | PRODUCT CODE: 1063047

Dermatology Drugs Global Market Report 2022

Published: Pre-Order
PAGES: 300 Pages
DELIVERY TIME: 2-10 business days
SELECT AN OPTION
PDF (Single User License)
USD 5000
PDF (Site License)
USD 7500
PDF (Enterprise License)
USD 10000

Add to Cart

“Dermatology Drugs Global Market Report 2022” from The Business Research Company provides the strategists, marketers and senior management with the critical information they need to assess the global dermatology drugs market as it emerges from the Covid 19 shut down.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order.

Where is the largest and fastest growing market for the dermatology drugs? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? “The Dermatology Drugs market global report” from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography. It places the market within the context of the wider dermatology drugs market, and compares it with other markets.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, the impact of the Covid 19 virus and forecasting its recovery.
  • Market segmentations break down market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the impact and recovery trajectory of Covid 19 for all regions, key developed countries and major emerging markets.
  • Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
  • The dermatology drugs market section of the report gives context. It compares the dermatology drugs market with other segments of the pharmaceutical drugs market by size and growth, historic and forecast. It analyses GDP proportion, expenditure per capita, dermatology drugs indicators comparison.

Scope

Markets Covered:

  • 1) By Type: Pharmaceutical Drugs; Biologics
  • 2) By Drug Type: Acne; Dermatitis; Psoriasis; Alopecia; Other Drugs
  • 3) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies/ Drug Stores; Others
  • 4) By Route Of Administration: Oral; Parenteral; Others
  • 5) By Drug Classification: Branded Drugs; Generic Drugs
  • 6) By Mode Of Purchase: Prescription-Based Drugs; Over-The-Counter Drugs
  • Companies Mentioned: Amgen; Reckitt Benckiser Group plc.; AbbVie; Galderma S.A.; LEO Pharma A/S; Bayer AG
  • Metrics Covered: Number of Enterprises; Number of Employees
  • Countries: Argentina; Australia; Austria; Belgium; Brazil; Canada; Chile; China; Colombia; Czech Republic; Denmark; Egypt; Finland; France; Germany; Hong Kong; India; Indonesia; Ireland; Israel; Italy; Japan; Malaysia; Mexico; Netherlands; New Zealand; Nigeria; Norway; Peru; Philippines; Poland; Portugal; Romania; Russia; Saudi Arabia; Singapore; South Africa; South Korea; Spain; Sweden; Switzerland; Thailand; Turkey; UAE; UK; USA; Venezuela; Vietnam
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita, dermatology drugs indicators comparison.
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Product Code: r675

Table of Contents

1. Executive Summary

2. Report Structure

3. Dermatology Drugs Market Characteristics

  • 3.1. Market Definition
  • 3.2. Key Segmentations

4. Dermatology Drugs Market Product Analysis

  • 4.1. Leading Products/ Services
  • 4.2. Key Features and Differentiators
  • 4.3. Development Products

5. Dermatology Drugs Market Supply Chain

  • 5.1. Supply Chain
  • 5.2. Distribution
  • 5.3. End Customers

6. Dermatology Drugs Market Customer Information

  • 6.1. Customer Preferences
  • 6.2. End Use Market Size and Growth

7. Dermatology Drugs Market Trends And Strategies

8. Impact Of COVID-19 On Dermatology Drugs

9. Dermatology Drugs Market Size And Growth

  • 9.1. Market Size
  • 9.2. Historic Market Growth, Value ($ Billion)
    • 9.2.1. Drivers Of The Market
    • 9.2.2. Restraints On The Market
  • 9.3. Forecast Market Growth, Value ($ Billion)
    • 9.3.1. Drivers Of The Market
    • 9.3.2. Restraints On The Market

10. Dermatology Drugs Market Regional Analysis

  • 10.1. Global Dermatology Drugs Market, 2021, By Region, Value ($ Billion)
  • 10.2. Global Dermatology Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Region
  • 10.3. Global Dermatology Drugs Market, Growth And Market Share Comparison, By Region

11. Dermatology Drugs Market Segmentation

  • 11.1. Global Dermatology Drugs Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Pharmaceutical Drugs
  • Biologics
  • 11.2. Global Dermatology Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Acne
  • Dermatitis
  • Psoriasis
  • Alopecia
  • Other Drugs
  • 11.3. Global Dermatology Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Hospital Pharmacies
  • Retail Pharmacies/ Drug Stores
  • Others
  • 11.4. Global Dermatology Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Oral
  • Parenteral
  • Others
  • 11.5. Global Dermatology Drugs Market, Segmentation By Drug Classification, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Branded Drugs
  • Generic Drugs
  • 11.6. Global Dermatology Drugs Market, Segmentation By Mode Of Purchase, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Prescription-Based Drugs
  • Over-The-Counter Drugs

12. Dermatology Drugs Market Metrics

  • 12.1. Dermatology Drugs Market Size, Percentage Of GDP, 2016-2026, Global
  • 12.2. Per Capita Average Dermatology Drugs Market Expenditure, 2016-2026, Global

13. Asia-Pacific Dermatology Drugs Market

  • 13.1. Asia-Pacific Dermatology Drugs Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 13.2. Asia-Pacific, Dermatology Drugs Market, 2021, By Country, Value ($ Billion)
  • 13.3. Asia-Pacific, Dermatology Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Country
  • 13.4. Asia-Pacific, Dermatology Drugs Market, 2016-2021, 2021-2026F, 2031F, Growth And Market Share Comparison, By Country
  • 13.5. Asia-Pacific, Dermatology Drugs Market Metrics
    • 13.5.1. Per Capita Average Dermatology Drugs Expenditure, 2016-2026, Asia-Pacific Countries
  • 13.6. Asia-Pacific Dermatology Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • 13.7. Asia-Pacific Dermatology Drugs Market: Country Analysis
    • 13.7.1. China Dermatology Drugs Market
      • 13.7.1.1. China Dermatology Drugs Market Overview
      • 13.7.1.2. China Dermatology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
      • 13.7.1.3. China Dermatology Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
    • 13.7.2. Australia Dermatology Drugs Market
      • 13.7.2.1. Australia Dermatology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
      • 13.7.2.2. Australia Dermatology Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
    • 13.7.3. Hong Kong Dermatology Drugs Market
      • 13.7.3.1. Hong Kong Dermatology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
    • 13.7.4. India Dermatology Drugs Market
      • 13.7.4.1. India Dermatology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
      • 13.7.4.2. India Dermatology Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
    • 13.7.5. Indonesia Dermatology Drugs Market
      • 13.7.5.1. Indonesia Dermatology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
      • 13.7.5.2. Indonesia Dermatology Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
    • 13.7.6. Japan Dermatology Drugs Market
      • 13.7.6.1. Japan Dermatology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
      • 13.7.6.2. Japan Dermatology Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
    • 13.7.7. Malaysia Dermatology Drugs Market
      • 13.7.7.1. Malaysia Dermatology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
    • 13.7.8. New Zealand Dermatology Drugs Market
      • 13.7.8.1. New Zealand Dermatology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
    • 13.7.9. Philippines Dermatology Drugs Market
      • 13.7.9.1. Philippines Dermatology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
    • 13.7.10. Singapore Dermatology Drugs Market
      • 13.7.10.1. Singapore Dermatology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
    • 13.7.11. South Korea Dermatology Drugs Market
      • 13.7.11.1. South Korea Dermatology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
      • 13.7.11.2. South Korea Dermatology Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
    • 13.7.12. Thailand Dermatology Drugs Market
      • 13.7.12.1. Thailand Dermatology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
    • 13.7.13. Vietnam Dermatology Drugs Market
      • 13.7.13.1. Vietnam Dermatology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

14. Western Europe Dermatology Drugs Market

  • 14.1. Western Europe Dermatology Drugs Market Overview
  • 14.2. Western Europe, Dermatology Drugs Market, 2021, By Country, Value ($ Billion)
  • 14.3. Western Europe, Dermatology Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Country
  • 14.4. Western Europe, Dermatology Drugs Market, 2016-2021, 2021-2026F, 2031F, Growth And Market Share Comparison, By Country
  • 14.5. Western Europe, Dermatology Drugs Market Metrics
    • 14.5.1. Per Capita Average Dermatology Drugs Expenditure, 2016-2026, Western Europe Countries
  • 14.6. Western Europe Dermatology Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • 14.7. Western Europe Dermatology Drugs Market: Country Analysis
    • 14.7.1. Austria Dermatology Drugs Market
      • 14.7.1.1. Austria Dermatology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
    • 14.7.2. Belgium Dermatology Drugs Market
      • 14.7.2.1. Belgium Dermatology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
    • 14.7.3. Denmark Dermatology Drugs Market
      • 14.7.3.1. Denmark Dermatology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
    • 14.7.4. Finland Dermatology Drugs Market
      • 14.7.4.1. Finland Dermatology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
    • 14.7.5. France Dermatology Drugs Market
      • 14.7.5.1. France Dermatology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
      • 14.7.5.2. France Dermatology Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
    • 14.7.6. Germany Dermatology Drugs Market
      • 14.7.6.1. Germany Dermatology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
      • 14.7.6.2. Germany Dermatology Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
    • 14.7.7. Ireland Dermatology Drugs Market
      • 14.7.7.1. Ireland Dermatology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
    • 14.7.8. Italy Dermatology Drugs Market
      • 14.7.8.1. Italy Dermatology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
    • 14.7.9. Netherlands Dermatology Drugs Market
      • 14.7.9.1. Netherlands Dermatology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
    • 14.7.10. Norway Dermatology Drugs Market
      • 14.7.10.1. Norway Dermatology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
    • 14.7.11. Portugal Dermatology Drugs Market
      • 14.7.11.1. Portugal Dermatology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
    • 14.7.12. Spain Dermatology Drugs Market
      • 14.7.12.1. Spain Dermatology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
    • 14.7.13. Sweden Dermatology Drugs Market
      • 14.7.13.1. Sweden Dermatology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
    • 14.7.14. Switzerland Dermatology Drugs Market
      • 14.7.14.1. Switzerland Dermatology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
    • 14.7.15. UK Dermatology Drugs Market
      • 14.7.15.1. UK Dermatology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
      • 14.7.15.2. UK Dermatology Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

15. Eastern Europe Dermatology Drugs Market

  • 15.1. Eastern Europe Dermatology Drugs Market Overview
  • 15.2. Eastern Europe, Dermatology Drugs Market, 2021, By Country, Value ($ Billion)
  • 15.3. Eastern Europe, Dermatology Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Country
  • 15.4. Eastern Europe, Dermatology Drugs Market, 2016-2021, 2021-2026F, 2031F, Growth And Market Share Comparison, By Country
  • 15.5. Eastern Europe, Dermatology Drugs Market Metrics
    • 15.5.1. Per Capita Average Dermatology Drugs Expenditure, 2016-2026, Eastern Europe Countries
  • 15.6. Eastern Europe Dermatology Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • 15.7. Eastern Europe Dermatology Drugs Market: Country Analysis
    • 15.7.1. Czech Republic Dermatology Drugs Market,
      • 15.7.1.1. Czech Republic Dermatology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
    • 15.7.2. Poland Dermatology Drugs Market
      • 15.7.2.1. Poland Dermatology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
    • 15.7.3. Romania Dermatology Drugs Market
      • 15.7.3.1. Romania Dermatology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
    • 15.7.4. Russia Dermatology Drugs Market
      • 15.7.4.1. Russia Dermatology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
      • 15.7.4.2. Russia Dermatology Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

16. North America Dermatology Drugs Market

  • 16.1. North America Dermatology Drugs Market Overview
  • 16.2. North America, Dermatology Drugs Market, 2021, By Country, Value ($ Billion)
  • 16.3. North America, Dermatology Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Country
  • 16.4. North America, Dermatology Drugs Market, 2016-2021, 2021-2026F, 2031F, Growth And Market Share Comparison, By Country
  • 16.5. North America, Dermatology Drugs Market Metrics
    • 16.5.1. Per Capita Average Dermatology Drugs Expenditure, 2016-2026, North America Countries
  • 16.6. North America Dermatology Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • 16.7. North America Dermatology Drugs Market: Country Analysis
    • 16.7.1. Canada Dermatology Drugs Market
      • 16.7.1.1. Canada Dermatology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
    • 16.7.2. Mexico Dermatology Drugs Market
      • 16.7.2.1. Mexico Dermatology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
    • 16.7.3. USA Dermatology Drugs Market
      • 16.7.3.1. USA Dermatology Drugs Market Overview
      • 16.7.3.2. USA Dermatology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
      • 16.7.3.3. USA Dermatology Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

17. South America Dermatology Drugs Market

  • 17.1. South America Dermatology Drugs Market Overview
  • 17.2. South America, Dermatology Drugs Market, 2021, By Country, Value ($ Billion)
  • 17.3. South America, Dermatology Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Country
  • 17.4. South America, Dermatology Drugs Market, 2016-2021, 2021-2026F, 2031F, Growth And Market Share Comparison, By Country
  • 17.5. South America, Dermatology Drugs Market Metrics
    • 17.5.1. Per Capita Average Dermatology Drugs Expenditure, 2016-2026, South America Countries
  • 17.6. South America Dermatology Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • 17.7. South America Dermatology Drugs Market: Country Analysis
    • 17.7.1. Argentina Dermatology Drugs Market
      • 17.7.1.1. Argentina Dermatology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
    • 17.7.2. Brazil Dermatology Drugs Market
      • 17.7.1.1. Brazil Dermatology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
      • 17.7.2.2. Brazil Dermatology Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
    • 17.7.3. Chile Dermatology Drugs Market
      • 17.7.3.1. Chile Dermatology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
    • 17.7.4. Colombia Dermatology Drugs Market
      • 17.7.4.1. Colombia Dermatology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
    • 17.7.5. Peru Dermatology Drugs Market
      • 17.7.5.1. Peru Dermatology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
    • 17.7.6. Venezuela Dermatology Drugs Market
      • 17.7.6.1. Venezuela Dermatology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

18. Middle East Dermatology Drugs Market

  • 18.1. Middle East Dermatology Drugs Market Overview
  • 18.2. Middle East, Dermatology Drugs Market, 2021, By Country, Value ($ Billion)
  • 18.3. Middle East, Dermatology Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Country
  • 18.4. Middle East, Dermatology Drugs Market, 2016-2021, 2021-2026F, 2031F, Growth And Market Share Comparison, By Country
  • 18.5. Middle East, Dermatology Drugs Market Metrics
    • 18.5.1. Per Capita Average Dermatology Drugs Expenditure, 2016-2026, Middle East Countries
  • 18.6. Middle East Dermatology Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • 18.7. Middle East Dermatology Drugs Market: Country Analysis
    • 18.7.1. Saudi Arabia Dermatology Drugs Market
      • 18.7.1.1. Saudi Arabia Dermatology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
    • 18.7.2. Israel Dermatology Drugs Market
      • 18.7.2.1. Israel Dermatology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
    • 18.7.3. Turkey Dermatology Drugs Market
      • 18.7.3.1. Turkey Dermatology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
    • 18.7.4. UAE Dermatology Drugs Market
      • 18.7.4.1. UAE Dermatology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

19. Africa Dermatology Drugs Market

  • 19.1. Africa Dermatology Drugs Market Overview
  • 19.2. Africa, Dermatology Drugs Market, 2021, By Country, Value ($ Billion)
  • 19.3. Africa, Dermatology Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Country
  • 19.4. Africa, Dermatology Drugs Market, 2016-2021, 2021-2026F, 2031F, Growth And Market Share Comparison, By Country
  • 19.5. Africa, Dermatology Drugs Market Metrics
    • 19.5.1. Per Capita Average Dermatology Drugs Expenditure, 2016-2026, Africa Countries
  • 19.6. Africa Dermatology Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • 19.7. Africa Dermatology Drugs Market: Country Analysis
    • 19.7.1. Egypt Dermatology Drugs Market
      • 19.7.1.1. Egypt Dermatology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
    • 19.7.2. Nigeria Dermatology Drugs Market
      • 19.7.2.1. Nigeria Dermatology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
    • 19.7.3. South Africa Dermatology Drugs Market
      • 19.7.3.1. South Africa Dermatology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

20. Dermatology Drugs Market Competitive Landscape

  • 20.1. Competitive Market Overview
  • 20.2. Market Shares
  • 20.3. Company Profiles
    • 20.3.1. Amgen
      • 20.3.1.1. Company Overview
      • 20.3.1.2. Products And Services
      • 20.3.1.3. Strategy
      • 20.3.1.4. Financial Performance
    • 20.3.2. Reckitt Benckiser Group plc
      • 20.3.2.1. Company Overview
      • 20.3.2.2. Products And Services
      • 20.3.2.3. Strategy
      • 20.3.2.4. Financial Performance
    • 20.3.3. AbbVie
      • 20.3.3.1. Company Overview
      • 20.3.3.2. Products And Services
      • 20.3.3.3. Strategy
      • 20.3.3.4. Financial Performance
    • 20.3.4. Galderma S.A.
      • 20.3.4.1. Company Overview
      • 20.3.4.2. Products And Services
      • 20.3.4.3. Strategy
      • 20.3.4.4. Financial Performance
    • 20.3.5. LEO Pharma A/S
      • 20.3.5.1. Company Overview
      • 20.3.5.2. Products And Services
      • 20.3.5.3. Strategy
      • 20.3.5.4. Financial Performance

21. Key Mergers And Acquisitions In The Dermatology Drugs Market

22. Market Background: Pharmaceutical Drugs Market

  • 22.1. Pharmaceutical Drugs Market Characteristics
  • 22.2. Pharmaceutical Drugs Market Historic and Forecast, 2016-2021, 2021-2026F, 2031F Growth, By Segment, Value ($ Billion), Global
  • 22.3. Global Pharmaceutical Drugs Market, 2021, By Region, Value ($ Billion)
  • 22.4. Global Pharmaceutical Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Region
  • 22.5. Global Pharmaceutical Drugs Market, 2016-2021, 2021-2026F, 2031F, Segmentation By Type, Value ($ Billion)

23. Recommendations

  • 23.1. Global Dermatology Drugs Market In 2026- Growth Countries
  • 23.2. Global Dermatology Drugs Market In 2026- Growth Segments
  • 23.3. Global Dermatology Drugs Market In 2026- Growth Strategies

24. Appendix

  • 24.1. NAICS Definitions Of Industry Covered In This Report
  • 24.2. Abbreviations
  • 24.3. Currencies
  • 24.4. Research Inquiries
  • 24.5. The Business Research Company

25. Copyright And Disclaimer

Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!